Pharmaceuticals, Biotechnology and Life Sciences
Emblem Corp, licensed producer and distributor of medical cannabis and cannabis derivatives in Canada, said Monday that that its director…
Allergan said Monday it has named Matt Walsh, an experienced Chief Financial Officer, to lead the financial sector of the…
GW Pharmaceuticals, a biopharmaceutical company focused on making and selling therapeutics from its cannabinoid product platform, said Monday that the…
Shire said on Monday that it will have 12 presentations at the 14th annual WORLDSymposium 2018 in San Diego, in…
Nymox Pharmaceutical will submit a New Drug Application (NDA) for Fexapotide Triflutate for the treatment of BPH in the US,…
Adventist Health—a faith-based, nonprofit integrated health system serving more than 75 communities in California, Oregon and Hawaii—has received a positive…
As a media partner for this year’s Pharmapack event in Paris, Pharmaceutical Daily has interviewed Elena Piazza, Business Development and…
At Pharmapack in Paris, Spang & Brands is going to spotlight two innovative pharmaceutical devices: A single-use nasal dosing device…
Allergan’s supplemental New Drug Application (sNDA) to expand the approved use of AVYCAZ has gotten the FDA’s approval.
AstraZeneca’s revenues improved over the course of the year, Pascal Soriot, Chief Executive Officer, commenting on the results said on…